Abstract
BAG-1 is a multifunctional protein that interacts with a wide range of cellular targets including heat-shock proteins and some nuclear hormone receptors. BAG-1 exists as three major isoforms, BAG-1L, BAG-1M and BAG-1S. BAG-1L contains a nuclear localization signal, which is not present in the other isoforms, and is predominantly localized in the cell nucleus. Here we have investigated the effects of BAG-1 on function of the oestrogen receptor (ER), a key growth control molecule and target for hormonal therapy in breast cancer. We demonstrate that BAG-1L, but not BAG-1S or BAG-1M, increased oestrogen-dependent transcription in breast cancer cells. BAG-1L interacted with and stimulated the activity of both ER α and β. Although BAG-1L and ERs colocalize to the nucleus, fusing BAG-1S to an heterologous nuclear localization sequence was not sufficient to stimulate transcription. Consistent with an important effect on receptor function, nuclear BAG-1 expression in breast cancers was associated with expression of the progesterone receptor, a transcriptional target of ERα, and was associated with improved survival in patients treated with hormonal therapy. These data suggest that BAG-1L is an important determinant of ER function in vitro and in human breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Society of Clinical Oncology (1996). J. Clin. Oncol., 14, 2843–2877.
Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C and Comoglio PM . (1996). EMBO J, 15, 6205–6212.
Bloom HJG and Richardson WW . (1957). Br. J. Cancer, 1957, 359–377.
Briknarova K, Takayama S, Brive L, Havert ML, Knee DA, Velasco J, Homma S, Cabezas E, Stuart J, Hoyt DW, Satterthwait AC, Llinas M, Reed JC and Ely KR . (2001). Nat. Struct. Biol.Pl. provide volume no., 8, 349–352.
Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, Lakhani SR and Packham G . (1999). Br. J. Cancer, 81, 1042–1051.
Cato AC and Mink S . (2001). J. Steroid Biochem. Mol. Biol., 78, 379–388.
Cheung J and Smith DF . (2000). Mol Endocrinol., 14, 939–946.
Clemons M and Goss P . (2001). N. Engl. J. Med., 344, 276–285.
Clevenger CV, Thickman K, Ngo W, Chang WP, Takayama S and Reed JC . (1997). Mol. Endocrinol., 11, 608–618.
Colditz GA . (1998). J. Natl. Cancer Inst., 90, 814–823.
Coldwell MJ, deSchoolmeester ML, Fraser GA, Pickering BM, Packham G and Willis AE . (2001). Oncogene, 20, 4095–4100.
Cutress RI, Townsend PA, Bateman AC, Johnson PW, Ryder K, Barnes DM and Packham G . (2001). J. Clin Oncol., 19, 3706–3707.
Cutress RI, Townsend PA, Brimmell M, Bateman AC, Hague A and Packham G . (2002). Bri. J. Cancer, 87, 834–839.
Dickson RB and Stancel GM . (2000). J. Natl. Cancer Inst. Monogr., 27, 135–145.
Early Breast Cancer Trialists' Collaborative Group. (1998). Lancet, 351, 1451–1467.
Elston CW and Ellis IO . (1991). Histopathology, 19, 403–410.
Foster JS, Henley DC, Ahamed S and Wimalasena J . (2001). Trends Endocrinol Metabol., 12, 320–327.
Froesch BA, Takayama S and Reed JC . (1998). J. Biol. Chem., 273, 11660–11666.
Guzey M, Takayama S and Reed JC . (2000). J. Biol. Chem., 275, 40749–40756.
Hague A, Packham G, Huntley S, Shefford K and Eveson JW . (2002). J. Pathol., 197, 60–71.
Hohfeld J . (1998). Biol. Chem., 379, 269–274.
Horwitz KB, Koseki Y and McGuire WL . (1978). Endocrinology, 103, 1742–1751.
Horowitz KB and McGuire WL . (1975). Science, 189, 726–727.
Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS and McCarty Jr KS . (1989). Cancer Res, 49, 1052–1056.
Knee DA, Froesch BA, Nuber U, Takayama S and Reed JC . (2001). J. Biol. Chem., 276, 12718–12724.
Kudoh M, Knee DA, Takayama S and Reed JC . (2002). Cancer Res., 62, 1904–1909.
Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U and Cato AC . (1998). J. Biol. Chem., 273, 14620–14625.
Liu R, Takayama S, Zheng Y, Froesch B, Chen GQ, Zhang X, Reed JC and Zhang XK . (1998). J. Biol. Chem., 273, 16985–16992.
Mandlekar S and Kong A-NT . (2001). Apoptosis, 6, 469–477.
Niyaz Y, Zeiner M and Gehring U . (2001). J. Cell Sci., 114, 10–45.
Pace P, Taylor J, Suntharalingam S, Coombes RC and Ali S . (1997). J. Biol. Chem., 272, 25832–25838.
Packham G, Brimmell M and Cleveland JL . (1997). Biochem. J., 328, 807–813.
Pratt WB and Toft DO . (1997). Endocrine Rev., 18, 306–360.
Rorke S, Murphy S, Khalifa M, Chernenko G and Tang SC . (2001). Int. J. Cancer, 95, 317–322.
Schulz JB, Bremen D, Reed JC, Lommatzsch J, Takayama S, Wullner U, Loschmann PA, Klockgether T and Weller M . (1997). J. Neurochem., 69, 2075–2086.
Shindoh M, Adachi M, Higashino F, Yasuda M, Hida K, Nishioka T, Ono M, Takayama S, Reed JC, Imai K, Totsuka Y and Kohgo T . (2000). Oral Oncol., 36, 444–449.
Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC and Imai K . (1997). Oncogene, 14, 2971–2977.
Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K, Knee D, Scudiero D, Tudor G, Miller GJ, Miyashita T, Yamada M and Reed JC . (1998). Cancer Res., 58, 3116–3131.
Takayama S and Reed J . (2001). Nat. Cell Biol., 3, 237–241.
Tang SC, Shaheta N, Chernenko G, Khalifa M and Wang X . (1999). J. Clin. Oncol., 17, 1710–1719.
Townsend PA, Dublin E, Hart IR, Kao R-H, Hanby AM, Cutress RI, Poulsom R, Ryder K, Barnes DM and Packham G . (2002). J. Pathol., 197, 51–59.
Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D, Rebbeck TR, Haffty BG and Reed JC . (2001). J. Clin. Oncol., 19, 992–1000.
Wang HG, Takayama S, Rapp UR and Reed JC . (1996). Proc. Natl. Acad. Sci. USA, 93, 7063–7068.
Witcher M, Yang X, Pater A and Tang SC . (2001). Exp. Cell Res., 265, 167–173.
Yamauchi H, Adachi M, Sakata K, Hareyama M, Satoh M, Himi T, Takayama S, Reed JC and Imai K . (2001). Cancer Lett., 165, 103–110.
Yang X, Chernenko G, Hao Y, Ding Z, Pater MM, Pater A and Tang SC . (1998). Oncogene, 17, 981–989.
Yang X, Hao Y, Ding Z, Pater A and Tang SC . (1999a). Clin. Cancer Res., 5, 1816–1822.
Yang X, Hao Y, Ferenczy A, Tang SC and Pater A . (1999b). Exp. Cell Res., 247, 200–207.
Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC and Imai K . (1998). Oncogene, 16, 2681–2686.
Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG, Adamson E and Reed JC . (1998). Breast Cancer Res. Treat., 47, 129–140.
Zeiner M and Gehring U . (1995). Proc. Natl. Acad. Sci. USA, 92, 11465–11469.
Zeiner M, Niyaz Y and Gehring U . (1999). Proc. Natl. Acad. Sci. USA, 96, 10194–10199.
Acknowledgements
We thank Dr S Ali for kind gifts of reagents. This research was supported by grants from the Association for International Cancer Research, Breast Cancer Campaign and the Cancer Research UK. R Cutress is supported by a Robertson Trust Training Fellowship from the Royal College of Surgeons of Edinburgh, and the 9th Guernsey Research Fellowship from Hope.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cutress, R., Townsend, P., Sharp, A. et al. The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription. Oncogene 22, 4973–4982 (2003). https://doi.org/10.1038/sj.onc.1206688
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206688
Keywords
This article is cited by
-
Non-AUG translation initiation in mammals
Genome Biology (2022)
-
Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer
BMC Cancer (2019)
-
Interaction between the BAG1S isoform and HSP70 mediates the stability of anti-apoptotic proteins and the survival of osteosarcoma cells expressing oncogenic MYC
BMC Cancer (2019)
-
Comment on ‘BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses'
British Journal of Cancer (2018)
-
BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses
British Journal of Cancer (2017)